Literature DB >> 27694320

Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

Joanne L Mitchell1, Ausra S Lionikiene1, Georgi Georgiev1, Anja Klemmer1, Chelsea Brain1, Paul Y Kim2, Nicola J Mutch1.   

Abstract

Activated factor XII (FXIIa) has plasminogen activator capacity but its relative contribution to fibrinolysis is considered marginal compared with urokinase and tissue plasminogen activator. Polyphosphate (polyP) is released from activated platelets and mediates FXII activation. Here, we investigate the contribution of polyP to the plasminogen activator function of αFXIIa. We show that both polyP70, of the chain length found in platelets (60-100 mer), and platelet-derived polyP significantly augment the plasminogen activation capacity of αFXIIa. PolyP70 stimulated the autoactivation of FXII and subsequent plasminogen activation, indicating that once activated, αFXIIa remains bound to polyP70 Indeed, complex formation between polyP70 and αFXIIa provides protection against autodegradation. Plasminogen activation by βFXIIa was minimal and not enhanced by polyP70, highlighting the importance of the anion binding site. PolyP70 did not modulate plasmin activity but stimulated activation of Glu and Lys forms of plasminogen by αFXIIa. Accordingly, polyP70 was found to bind to FXII, αFXIIa, and plasminogen, but not βFXIIa. Fibrin and polyP70 acted synergistically to enhance αFXIIa-mediated plasminogen activation. The plasminogen activator activity of the αFXIIa-polyP70 complex was modulated by C1 inhibitor and histidine-rich glycoprotein, but not plasminogen activator inhibitors 1 and 2. Platelet polyP and FXII were found to colocalize on the activated platelet membrane in a fibrin-dependent manner and decorated fibrin strands extending from platelet aggregates. We show that in the presence of platelet polyP and the downstream substrate fibrin, αFXIIa is a highly efficient and favorable plasminogen activator. Our data are the first to document a profibrinolytic function of platelet polyP.
© 2016 by The American Society of Hematology.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27694320      PMCID: PMC5325051          DOI: 10.1182/blood-2015-10-673285

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  65 in total

1.  Factor XIIa is a kinetically favorable plasminogen activator.

Authors:  I Schousboe; K Feddersen; R Røjkjaer
Journal:  Thromb Haemost       Date:  1999-09       Impact factor: 5.249

2.  Factor XII regulates the pathological process of thrombus formation on ruptured plaques.

Authors:  Marijke J E Kuijpers; Paola E J van der Meijden; Marion A H Feijge; Nadine J A Mattheij; Frauke May; José Govers-Riemslag; Joost C M Meijers; Johan W M Heemskerk; Thomas Renné; Judith M E M Cosemans
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-05-22       Impact factor: 8.311

Review 3.  Inorganic polyphosphate: a molecule of many functions.

Authors:  A Kornberg; N N Rao; D Ault-Riché
Journal:  Annu Rev Biochem       Date:  1999       Impact factor: 23.643

4.  The effects of fibrinogen and its cleavage products on the kinetics of plasminogen activation by urokinase and subsequent plasmin activity.

Authors:  M A Lucas; D L Straight; L J Fretto; P A McKee
Journal:  J Biol Chem       Date:  1983-10-25       Impact factor: 5.157

5.  Studies of the release from human platelets of the growth factor for cultured human arterial smooth muscle cells.

Authors:  L D Witte; K L Kaplan; H L Nossel; B A Lages; H J Weiss; D S Goodman
Journal:  Circ Res       Date:  1978-03       Impact factor: 17.367

6.  The activation of plasminogen by Hageman factor (Factor XII) and Hageman factor fragments.

Authors:  G H Goldsmith; H Saito; O S Ratnoff
Journal:  J Clin Invest       Date:  1978-07       Impact factor: 14.808

7.  Defective PDI release from platelets and endothelial cells impairs thrombus formation in Hermansky-Pudlak syndrome.

Authors:  Anish Sharda; Sarah H Kim; Reema Jasuja; Srila Gopal; Robert Flaumenhaft; Barbara C Furie; Bruce Furie
Journal:  Blood       Date:  2015-01-15       Impact factor: 22.113

8.  Fibrinolytic properties of activated FXII.

Authors:  E A Braat; G Dooijewaard; D C Rijken
Journal:  Eur J Biochem       Date:  1999-08

9.  A comparison of the abilities of plasma kallikrein, beta-Factor XIIa, Factor XIa and urokinase to activate plasminogen.

Authors:  L A Miles; J S Greengard; J H Griffin
Journal:  Thromb Res       Date:  1983-02-15       Impact factor: 3.944

10.  Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation.

Authors:  Coen Maas; José W P Govers-Riemslag; Barend Bouma; Bettina Schiks; Bouke P C Hazenberg; Henk M Lokhorst; Per Hammarström; Hugo ten Cate; Philip G de Groot; Bonno N Bouma; Martijn F B G Gebbink
Journal:  J Clin Invest       Date:  2008-09       Impact factor: 14.808

View more
  10 in total

Review 1.  From underlying chemistry to therapeutic potential: open questions in the new field of lysine polyphosphorylation.

Authors:  Amanda Bentley-DeSousa; Michael Downey
Journal:  Curr Genet       Date:  2018-06-07       Impact factor: 3.886

2.  Live-cell Imaging of Platelet Degranulation and Secretion Under Flow.

Authors:  Arjan D Barendrecht; Johan J F Verhoef; Silvia Pignatelli; Gerard Pasterkamp; Harry F G Heijnen; Coen Maas
Journal:  J Vis Exp       Date:  2017-07-10       Impact factor: 1.355

3.  A mutation in the kringle domain of human factor XII that causes autoinflammation, disturbs zymogen quiescence, and accelerates activation.

Authors:  Zonne L M Hofman; Chantal C Clark; Wariya Sanrattana; Aziz Nosairi; Naomi M J Parr; Minka Živkovic; Karoline Krause; Niklas A Mahnke; Jörg Scheffel; C Erik Hack; Marcus Maurer; Steven de Maat; Coen Maas
Journal:  J Biol Chem       Date:  2019-11-26       Impact factor: 5.157

Review 4.  Recent advances in targeted delivery of non-coding RNA-based therapeutics for atherosclerosis.

Authors:  Xiaoxin Li; Hongzhao Qi; Weigang Cui; Zhibin Wang; Xiuxiu Fu; Tianxiang Li; Huibo Ma; Yanyan Yang; Tao Yu
Journal:  Mol Ther       Date:  2022-08-01       Impact factor: 12.910

Review 5.  Platelet Membrane Receptor Proteolysis: Implications for Platelet Function.

Authors:  Jiayu Wu; Johan W M Heemskerk; Constance C F M J Baaten
Journal:  Front Cardiovasc Med       Date:  2021-01-08

6.  uPA-mediated plasminogen activation is enhanced by polyphosphate.

Authors:  Claire S Whyte; Nicola J Mutch
Journal:  Haematologica       Date:  2021-02-01       Impact factor: 9.941

7.  Exposure of plasminogen and a novel plasminogen receptor, Plg-RKT, on activated human and murine platelets.

Authors:  Claire S Whyte; Gael B Morrow; Nagyung Baik; Nuala A Booth; Mohammed M Jalal; Robert J Parmer; Lindsey A Miles; Nicola J Mutch
Journal:  Blood       Date:  2021-01-14       Impact factor: 22.113

8.  The Procoagulant Activity of Apoptotic Cells Is Mediated by Interaction with Factor XII.

Authors:  Aizhen Yang; Fengwu Chen; Chao He; Junsong Zhou; Yi Lu; Jihong Dai; Raymond B Birge; Yi Wu
Journal:  Front Immunol       Date:  2017-09-25       Impact factor: 7.561

Review 9.  Immunohaemostasis: a new view on haemostasis during sepsis.

Authors:  Xavier Delabranche; Julie Helms; Ferhat Meziani
Journal:  Ann Intensive Care       Date:  2017-12-02       Impact factor: 6.925

Review 10.  Plasminflammation-An Emerging Pathway to Bradykinin Production.

Authors:  Coen Maas
Journal:  Front Immunol       Date:  2019-08-27       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.